Article
Ultrasound and magnetic resonance imaging for group stratification and treatment monitoring in the transgenic adenocarcinoma of the mouse prostate model.
The Prostate - 1 Feb 2020
Fagerland Stein-Martin T, Hill Deborah K, van Wamel Annemieke, de Lange Davies Catharina, Kim Jana
Abstract excerpt
BACKGROUND: The transgenic adenocarcinoma of the mouse prostate (TRAMP) is a widely used genetically engineered spontaneous prostate cancer model. However, both the degree of malignancy and time of cancer onset vary. While most mice display slowly progressing cancer, a subgroup develops fast-growing poorly differentiated (PD) tumors, making the model challenging to use. We investigated the feasibility of using...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.